Patients suspected of dementia can proceed with an Amyloid PET-Scan in our department for further investigation. This examination features robust and ad...
The launch of the new radiopharmaeutical Neuraceq® (18F Florbetaben, “FBB”) for our Amyloid PET scan services is recently introduced in a press release...
We are pleased to announce that our Cyclotron Pharmaceutical Centre will launch the new radiopharmaceutical Neuraceq® (18F Florbetaben, hereinafter “FBB...
Diagnosis of Parkinson’s disease is mainly based on the patient’s medical history as well as neurological signs and symptoms. In recent years, neurologi...
Prostate cancer is one of the most common cancers in men in Hong Kong. MRI and PET/CT scans are the key imaging examinations for diagnosing prostate can...
Amyloid plaque deposition in the brain is found in Alzheimer's Disease patients. Since 2019, our department has been providing PET scan services which c...
Our department is the first medical imaging centre on the Kowloon side of Hong Kong to offer this revolutionary imaging technology to the general public...